Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

BiOasis Technologies Inc V.BTI

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  BIOAF

biOasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders.
Price: $0.94 | Change: +$0.04 | %Change: +4.44%
Volume: 71,000 | Day High/Low: 0.94/0.89 | 52 Week High/Low: 1.35/0.67


Last Traded: October 21, 2014 11:46 Transaction Volume: 71,000
Open: $0.94 Previous Close: $0.90
Bid: $0.91 Ask: $0.95
Bid Size: 3,000 Ask Size: 500
Market Cap: $41.4m Shares Out: 44.0m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts


Haywood snaps up 10,000 BiOasis shares (V.BTI)

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   September 30, 2013
0 stars

Latest Bullboard Posts

  • RE:RE:Alzheimer’s ?

    5 stars

    I was thinking similar things, jawcellis. Glen Campbell, who is now at an advanced stage of the disease, was in the news recently. The...

    2.5 stars

  • RE:Alzheimer’s ?

    0 stars

    I wish for my Father who is 86 that we could speed things up.  He has dementia now and will get worse.  We all fear Altzhimer's disease. ...

    2 stars

  • RE:Alzheimer’s ?

    3.5 stars

    Thanks for posting that, KayakerBC. I had never seen that before. It's quite recent, too, having been released in August. I guess I'm...

    2.5 stars

  • Alzheimer’s ?

    3 stars

    In the BTI March 17 news release, Dr. Carl Webster is mentioned (Associate Director, Antibody Discovery and Protein Engineering...

    2.5 stars

  • RE:Shire & Abbvie

    2 stars

    Inversion Implosion: AbbVie-Shire Merger Officially Dead Nathan Vardi Nathan Vardi Forbes Staff After the government revised the rules...

    2.5 stars